Profile details
About Jeffrey Gould
Jeff has extensive experience in capital markets transactions, representing issuers on a wide range of public and private securities offerings, including IPOs, follow-on equity offerings, investment grade and high yield debt offerings, convertible notes transactions, particularly within the context of technology and life sciences companies. He also regularly advises clients on SEC compliance, disclosure and corporate governance matters.
Recent work
Jeff has advised issuers and underwriters in IPOs and a variety of other equity and debt capital markets transactions including:
- Follow-on and other stock offerings: Carvana, Cryoport, Five Prime Therapeutics, Il-VI Incorporated, Lucid Group, Maravai LifeSciences Holdings, Natera, Nextracker, Pandora Music, SiTime
- Convertible notes offerings: 8x8, Accelerate Diagnostics, Accuray, Bloom Energy Corporation, Chegg, Coherus Biosciences, Coupa Software, Cryoport, DexCom, E*TRADE, Enphase, Five9, Groupon, Heska Corporation, Il-VI Incorporated, Insight Enterprises, Ionis Pharmaceuticals, Lucid Group, Marathon Digital Holdings, Medallia, NanoString Technologies, Natera, NeoGenomics, Nutanix, NuVasive, Palo Alto Networks, Pandora Music, Pure Storage, Twitter, Xometry
- High-yield offerings: Carvana, Elastic, E*Trade, Twitter
- Investment grade offerings: Amazon, Citrix, E*Trade, Flex, Fortinet, Globe Life, Illumina, Intel, Juniper Networks